Biocon Chief Kiran Mazumdar Shaw says India is not an outsourced services country anymore, it is an innovation and knowledge partner.
These targeted medicines represent a completely new way to treat HER2-positive metastatic breast cancer, with which the company aims to help women in India live as long and as well as possible, he added.